The platform for microbial polysaccharides production enhances yield and purity
Biotechnology company Creative Biogene has optimised its platform for microbial polysaccharides production.
The new technology precisely regulates metabolic pathways in microorganisms. The process increases production yields and cuts operational expenses, facilitating scalable manufacturing for pharmaceutical applications.
“This has been a game-changing innovation in the field of polysaccharide production, This technology addresses the challenge by optimising yield and purity, resulting in a more efficient and sustainable production process,” said the chief expert at Creative Biogene.
Higher yields and increased purity are achieved through the technology’s focus on strain optimisation and process intensification. By shortening fermentation cycles and increasing resource utilisation efficiency, the technology supports faster production turnaround while reducing environmental impact.
Microbial polysaccharides are biopolymers produced by microorganisms such as bacteria, yeast and fungi, which are useful for pharmaceuticals.
Curdlan and Alginate, for example, function as heat-gelling agents and wound care solutions.
Creative Biogene’s technology support other industries too, including food, cosmetics and materials science.
Recently, Creative Biogene also launched a line of gamma-retroviral products capable of efficiently delivering genes into various cell types.
